Are Shares Of Sixth Wave Innovations Setting Up For A Meteoric Sona-Style Move?

The nanotech market has grown 7-fold since 2010 and is forecast to hit $75 billion by 2021.

Herein lies opportunity for industry participants to tap the fast-growing market, which could garner huge revenue on the back of the commercialization of cutting-edge technologies.

Explosive capital gains have been generated by jumping into the right stock at the right juncture in its path toward commercialization.

Today more than ever, Nanotech companies have come to the fore as they scramble to find rapid solutions to the “new normal”.  Enabling “safe spaces” at home, work, public transportation and public spaces are paramount to containing and ultimately eliminating risk of spread.

Solutions are on the horizon and massive profits have already been realized by investors positioning early.

Shares in Sona Nanotech (CSE:SONA) soared from $0.13 in February hitting a high of $14.45 on July 27th for a heart pounding gain of over 11,000%. The company developed gold nanorods for use in lateral flow diagnostics for the detection of pathogens.

Kontrol Energy (CSE:KNR) has developed a real-time detection system by measuring air quality through their BioCloud device.  Kontrol’s shares were driven from $0.40 in June, hitting a high of $5.20 as of this writing – a gain of over 1500%.

We’ve been scanning the markets for the next Sona or Kontrol and may have found the answer.

Sixth Wave Innovations (CSE: SIXW, OTCQB: ATURF) molecularly imprinted polymers (MIPs) are unique in the market in that no other competitive product has the flexibility and scalability that a completely synthetic test offers. All the pieces in place for a Sona-style move.

The company’s market capitalization sits at just over CAD $20 million while Kontrol Energy is at $150 million and Sona holds a whopping $450 million.

Sixth Wave Innovations is led by a high profile, high performance team of scientists, accomplished executives and business development specialists. Their advisory board includes Hon. Grant Mitchell (Senator, Alberta), Hon. Jay Cohen (Rear Admiral, ret.) and Dr. David Fransen who has has provided strategic leadership across a wide range of economic policy and program sectors as a senior official at the Privy Council Office and Health Canada, as an Assistant Deputy Minister at Industry Canada.

The global antibody industry is worth $80 billion (Phys.Org) and relies heavily on animals to produce the antibodies that are used to detect the vast range of molecules indicative of state of health, safety or the environment. 

Sixth Wave’s patent-pending AMIPs are being designed to detect and capture a broad range of pathogens using highly scalable synthetic polymers rather than relying on antibodies harvested from animals.

The AMIPs platform is a paradigm shift away from inert masks and organic immunoassay-based tests being developed by companies such as Sona Nanotech and Immunoprecise.

Sixth Wave offers something new to ongoing efforts and aren’t just recycling/repurposing the same old technology that has been used for decades and has proven unable to handle the supply side of the current crisis.

Sixth Wave’s polymer-based nanotechnology holds potential to completely replace current “safe space” market offerings, putting the Company in a position to lead the way in the race for a durable, scalable, “green” and easy to use solution for detecting and ultimately containing viral spread.

The opportunity for investors?  Broader market has not yet caught on.  We suspect that as the story filters into the mainstream, Sixth Wave’s share price will more accurately reflect the potentially significant value surrounding their platform technologies as the company moves from R&D toward commercialization.

The company has also developed systems for the mining and life sciences verticals, both of which are nearing commercialization. Both hold potential to launch Sixth Wave into valuations that are multiples of today’s share price. Hot Stocks Review will delve into these game-changing platforms in a future update.

This article will focus on the seismic market potential for AMIPs and why we believe Sixth Wave Innovations (CSE: SIXW, OTCQB: ATURF) share performance can follow the footsteps of the meteoric rise of Sona Nanotech, Immunoprecise, Kontrol Energy and others racing to develop viable solutions.

AMIPs for Rapid Viral Detection

The AMIPs synthetic polymer system allows for extended shelf life, minimal storage and handling requirements and less sensitivity to temperature and light degradation versus traditional immunoassay products.

AMIPS vs Legacy Testing Methods

AMIPs advantages:

  • Synthetic polymer based system is more robust and stable than antibodies.
  • Single use, rapid test (strip or wipe) giving results in minutes.
  • Requires no special training.
  • Compatible with several simple formats including lateral flow tests.
  • Flexible, scalable and adaptable allowing for screening for multiple infections in one test.
  • Avoids supply chain issues associated with growing and transporting antibodies.

The platform is infinitely scalable and adaptable. AMIPs technology allows Sixth Wave to configure tests to screen for multiple infections at once. By detecting classes of viruses, researchers can deploy new diagnostics without cultivating antigens or collecting antibodies in the case of novel viruses.

Sixth Wave’s Smart Mask™

In development and in partnership with NeoCon International, Sixth Wave is currently designing Smart Mask™, envisioned to incorporate the use of AMIPS for rapid virus detection into an N95 Compliant, or other mask / respirator.

SmartMask offers completely new capabilities not available on the market, and is being designed to allow for the detection of a broad array of pathogens before the person arrives at a screening point, whether it be a school, hospital, workplace or transportation.

Smart Mask™ could provide the standard protective capabilities of an N95 mask, with the added interactive capability to alert the user that a target virus has been detected in the exhaled breath of the user.

SmartMask carries the potential to remove bottlenecks caused by slower, more expensive lateral flow tests at checkpoints.

Airborne Detection

Sixth Wave announced in June that it has entered into a partnership with York University and CTRI (Centre Technologique des Residus Industriels) to further develop AMIPs for the use in airborne viral detection systems.

The partnership intends to develop a prototype to be tested and used in a broad range of settings, including the public sector, private industry, hospitals, long term healthcare facilities and various forms of public transportation.

Investors Snapping Up “Safe Space” Stocks

Investors have already demonstrated their appetite for “safe space” systems by driving shares of Kontrol Energy to a market cap of $150 million. Shares in Gatekeeper Systems took off from $0.15 in May to hit a high of $0.95 in August when they announced the development of a contactless system for school buses that can determine body temperature within 20 milliseconds using thermal cameras and artificial intelligence.

Sixth Wave’s AMIPs platform is being developed to provide full spectrum solutions supporting a global “safe space” initiative. Their systems are designed to be infinitely scalable, easy to use and implement, and have a rapid development time for new detection signatures.

The combined market size potential for the company’s suite of offerings is significant.

Shares of Sona Nanotech were trading at under 0.20 when they announced their foray into pathogen detection. By the time the company announced progress on its prototype shares hit 0.70, then went on to skyrocket to $16 as optimization of their platform took place.

Sixth Wave Innovations (CSE: SIXW, OTCQB: ATURF) aims to have a Phase 1 prototype ready by Q1-2021 and planning a global rollout by Q3, setting up for what might kick off a significant run on the stock.

With a market capitalization of ~$20 million and the table set for strong growth ahead, investors snapping up shares today could quite conceivably be in for a Sona-style ride to glory.

The company is currently under the radar however this could change in short order as a very capable leadership team prepares to move Sixth Wave from an understated R&D firm to a full blown nanotechnology powerhouse.

Visit the company’s website to learn more:


While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter/report/commentary piece/article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Furthermore, it is certainly possible for errors or omissions to take place regarding the profiled company, in communications, writing and/or editing.

Nothing in this publication should be considered as personalized financial advice. We are not licensed under any securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. The information provided in this article is for informational purposes only and is not a recommendation to buy or sell any security. Please consult a licensed financial advisor before making any investment decision. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a website owned by Mountain Capital Corp (“Mountain”), (100 King Street West #5700, Toronto, Ontario). Mountain has been compensated by Sixth Wave Innovations Inc. (“SIXW”) in the form of cash payment via wire transfer to provide strategic digital media and data analytics services on behalf of the company for an undefined term. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision.

By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing Mountain Capital Corp, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

Please refer to our complete Disclaimer and Disclosure here